
By MATT RICHTEL from NYT Health https://ift.tt/2CimNB0

The combination of immunotherapy (Tecentriq) and chemotherapy (Abraxane) received accelerated approval for triple-negative breast cancer that is locally advanced or has spread, cannot be surgically removed, and has cells that have a protein called PD-L1, CNN reported.
Researchers found that the supplements taken by study subjects worked no better than a placebo in helping ward off depression.
Students with a greater number of daily asthma symptoms had more absences, less school work completed and poorer quality work, the study found.
In 2015, the FDA deemed the AquaAdvantage Salmon safe, marking the first U.S. approval of a genetically engineered animal intended for food, CNN reported. But in 2016, Congress said the salmon could not be sold in the United States until the FDA finalized labeling guidelines to inform consumers the product was genetically engineered.